VAERS Explorer
Back to explore

Report #2852890

Received Aug 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
NY
Recovered
Unknown
Vaccinated
—
Onset
Mar 6, 2024
Days to onset
—
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
MMRMEASLES + MUMPS + RUBELLA (MMR II)MERCK & CO. INC.UNKW024967—
MMRVMEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD)MERCK & CO. INC.UNKW024967—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No additional AE; Lot# valid for PROQUAD; an expired dose of MMRII was inadvertently administered to a patient.; This spontaneous report was received from a registered nurse and refers to a(n) patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies included sterile diluent (MERCK STERILE DILUENT) On an unknown date, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) lot #W024967 is an invalid lot number for Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live; but valid for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (Product lot number issue) expiration date: 05-Feb-2024 (strength dose number, dose, route and anatomical location were not provided) for prophylaxis. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (no details provided). It was confirmed that the vaccine did not undergo any temperature excursions. No adverse events reported.

Other medications

sterile diluent